½ÃÀ庸°í¼­
»óǰÄÚµå
1474881

½ºÆ¼¾î·¯ºí ½Ã½º ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® ¸®Æ÷Æ® : À¯Çüº°, ¿ëµµº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2024-2030³â)

Steerable Sheaths Market Size, Share & Trends Analysis Report, By Type (Single Use, Reprocessed), By Application (Electrophysiology Procedures, Interventional Cardiology Procedures), By End-use, By Region, And Segment Forecasts, 2024 - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 140 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

½ºÆ¼¾î·¯ºí ½Ã½º ½ÃÀåÀÇ ¼ºÀå°ú µ¿Çâ

Grand View Research, Inc.ÀÇ ÃֽЏ®Æ÷Æ®¿¡ µû¸£¸é ¼¼°èÀÇ ½ºÆ¼¾î·¯ºí ½Ã½º ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 13¾ï 1,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2024-2030³âÀÇ CAGRÀº 7.2%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ¿äÀÎÀº Àúħ½À ½Ã¼úÀÇ ¼ö¿ä, ½ÉÇ÷°ü & ½Å°æÁúȯÀÇ À¯º´·ü »ó½Â, ±â¼úÀÇ Áøº¸, ½Å±Ô ºÐ¾ß¿¡¼­ ¿ëµµÀÇ È®´ëÀÔ´Ï´Ù.

Ä«Å×ÅÍ ÀýÁ¦¼ú ½Ã¼ú °Ç¼ö Áõ°¡´Â ½ÃÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀýÁ¦¼úÀÇ ¼ö°¡ Áõ°¡ÇÔ¿¡ µû¶ó Ä«Å×ÅÍ ¾È³»¿¡ ÇʼöÀûÀÎ ºÎǰÀÎ ½ºÆ¼¾î·¯ºí ½Ã½º¿¡ ´ëÇÑ Á÷Á¢ÀûÀÎ ¼ö¿ä Áõ°¡°¡ °üÂûµË´Ï´Ù. ¶ÇÇÑ ½ºÆ¼¾î·¯ºí ½Ã½º´Â º¹ÀâÇÑ ÇØºÎÇÐÀû ±¸Á¶¸¦ Ž»öÇÒ ¼ö ÀÖ´Â Á¶ÀÛ¼ºÀ» ³ôÀ̰í, ¸ñÇ¥ ¿µ¿ª¿¡ µµ´ÞÇÒ ¼ö ÀÖ´Â À¯¿¬¼ºÀ» Á¦°øÇϸç, ȣȯ¼ºÀ» Çâ»ó½Ã۰í, ÅëÇÕµÈ ¿µ»ó ó¸® ±â´ÉÀ» ÅëÇØ ½Ã°¢È­ ±â´ÉÀ» °­È­ÇÕ´Ï´Ù.

±â¼úÀÇ ¹ßÀüÀº »õ·Î¿î ¿ëµµÀÇ °³¹ß ¹× °³¹æÇü ½Ã¼ú¿¡ ´ëÇÑ Á¤ÇÕ¼ºÀ» Áö¿øÇϰí ÀÖ½À´Ï´Ù. 2023³â 3¿ù À¯·´½ÉÀ帮µëÇùȸ(European Heart Rhythm Association)ÀÇ ¹ßÇ¥¿¡ µû¸£¸é Á¶Á¾ÀÌ °¡´ÉÇÑ ½Ã½º¿Í Àü±âÇØºÎÇÐ ¸ÅÇÎ(EAM) ½Ã½ºÅÛ°ú °°Àº ½Ã°¢È­ ±â¼úÀÇ °áÇÕÀº ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ°í ÀÖ´Ù, Ä«Å×ÅÍ ÀýÁ¦¼ú¿¡ °¡½ÃÈ­ °¡´ÉÇÑ ½ºÆ¼¾î·¯ºí ½Ã½º¸¦ »ç¿ëÇÏ¸é ºñ½Ã½ÃÈ­ ½ºÆ¼¾î·¯ºí ½Ã½º¿¡ ºñÇØ ¹æ»ç¼± ÇÇÆøÀÌ °¨¼ÒÇÑ´Ù°í ¹àÇû½À´Ï´Ù.

½ºÆ¼¾î·¯ºí ½Ã½º ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

  • À¯Çüº°·Î´Â ÀÏȸ¿ë ºÎ¹®ÀÌ 2023³â 95.6%ÀÇ ÃÖ´ë ¸ÅÃâ Á¡À¯À²·Î ½ÃÀåÀ» ÁÖµµÇß½À´Ï´Ù. ÀÌ ºÎ¹®ÀÇ ¼ºÀåÀº ÆíÀǼº°ú ºñ¿ë È¿À²¼º, Àç·á Çõ½Å, »ç¿ë ÆíÀǼº¿¡ ´ëÇÑ Á߿伺 ¶§¹®À¸·Î ºÐ¼®µË´Ï´Ù.
  • ¿ëµµº°·Î´Â Àü±â»ý¸®ÇÐÀû ½Ã¼ú ºÐ¾ß°¡ 2023³â 38.8%ÀÇ ÃÖ´ë ¸ÅÃâ Á¡À¯À²·Î ½ÃÀåÀ» ÁÖµµÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ ºÎ¹®ÀÇ ¼ºÀåÀº ºÎÁ¤¸ÆÀÇ À¯º´·ü Áõ°¡, Ä«Å×ÅÍ ÀýÁ¦¼úÀÇ Ã¤Åà Áõ°¡, ½ºÆ¼¾î·¯ºí ½Ã½ºÀÇ ¹ßÀüÀ¸·Î ÀÎÇÑ °ÍÀÔ´Ï´Ù.
  • ÃÖÁ¾ ¿ëµµº°·Î´Â ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC) ºÎ¹®ÀÌ ¿¹Ãø ±â°£ Áß °¡Àå ºü¸¥ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ ºÎ¹®ÀÇ ¼ºÀåÀº ½Ã¼ú ½Ã°£ ´ÜÃà, ³ôÀº ºñ¿ë È¿À²¼º, ȸº¹ ½Ã°£ ´ÜÃà, ¿Ü·¡ ȯÀÚ¿¡¼­ ½ºÆ¼¾î·¯ºí ½Ã½º °ü·Ã ½Ã¼úÀ» Àå·ÁÇÏ´Â Á¤ºÎ ±â°ü µî ½Ã¼úÀÇ Àúħ½À¼º ¶§¹®ÀÎ °ÍÀ¸·Î ºÐ¼®µË´Ï´Ù.
  • ºÏ¹Ì°¡ 2023³â 37.2%ÀÇ ¸ÅÃâ Á¡À¯À²·Î ½ÃÀåÀ» ÁÖµµÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ½ÉÇ÷°ü Áúȯ ¹ßº´·ü Áõ°¡, ³ôÀº ¼öÁØÀÇ ÀÇ·á ÀÎÇÁ¶ó, ÁÖ¿ä ±â¾÷ÀÇ Á¸Àç. ¶ÇÇÑ ¼ö¼úÀ» ¹Þ´Â ȯÀÚ ¼ö Áõ°¡¿Í ÃÖ¼Ò Ä§½À ¼ö¼ú¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ºÏ¹Ì ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¼¼°èÀÇ ½ºÆ¼¾î·¯ºí ½Ã½º ½ÃÀåÀÇ º¯¼ö, µ¿Çâ, ¹üÀ§

  • ½ÃÀå °èÅë Àü¸Á
    • ¸ð½ÃÀå Àü¸Á
    • °ü·Ã/ºÎ¼ö ½ÃÀå Àü¸Á
  • ½ÃÀå ¿ªÇÐ
    • ½ÃÀå ÃËÁø¿äÀÎ ºÐ¼®
    • ½ÃÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
  • ½ºÆ¼¾î·¯ºí ½Ã½º ½ÃÀå ºÐ¼® Åø
    • ¾÷°è ºÐ¼® - PorterÀÇ »ê¾÷ ºÐ¼®
    • PESTEL ºÐ¼®

Á¦4Àå ½ºÆ¼¾î·¯ºí ½Ã½º ½ÃÀå : À¯Çü ÃßÁ¤¡¤µ¿Ç⠺м®

  • ½ºÆ¼¾î·¯ºí ½Ã½º ½ÃÀå : À¯Çü ´ë½Ãº¸µå
  • ½ºÆ¼¾î·¯ºí ½Ã½º ½ÃÀå : À¯Çü º¯µ¿ ºÐ¼®
  • ½ºÆ¼¾î·¯ºí ½Ã½º ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø¡¤µ¿Ç⠺м®, 2018-2030³â

Á¦5Àå ½ºÆ¼¾î·¯ºí ½Ã½º ½ÃÀå : ¿ëµµ ÃßÁ¤¡¤µ¿Ç⠺м®

  • ½ºÆ¼¾î·¯ºí ½Ã½º ½ÃÀå : ¿ëµµ ´ë½Ãº¸µå
  • ½ºÆ¼¾î·¯ºí ½Ã½º ½ÃÀå : ¿ëµµ º¯µ¿ ºÐ¼®
  • ½ºÆ¼¾î·¯ºí ½Ã½º ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø¡¤µ¿Ç⠺м®, 2018-2030³â

Á¦6Àå ½ºÆ¼¾î·¯ºí ½Ã½º ½ÃÀå : ÃÖÁ¾ ¿ëµµ ÃßÁ¤¡¤µ¿Ç⠺м®

  • ½ºÆ¼¾î·¯ºí ½Ã½º ½ÃÀå : ÃÖÁ¾ ¿ëµµ ´ë½Ãº¸µå
  • ½ºÆ¼¾î·¯ºí ½Ã½º ½ÃÀå : ÃÖÁ¾ ¿ëµµ º¯µ¿ ºÐ¼®
  • ½ºÆ¼¾î·¯ºí ½Ã½º ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø¡¤µ¿Ç⠺м®, 2018-2030³â

Á¦7Àå ½ºÆ¼¾î·¯ºí ½Ã½º ½ÃÀå : Áö¿ª ÃßÁ¤¡¤µ¿Ç⠺м®

  • ¼¼°èÀÇ ½ºÆ¼¾î·¯ºí ½Ã½º ½ÃÀå : Áö¿ªÀÇ ´ë½Ãº¸µå
  • ¼¼°èÀÇ ½ºÆ¼¾î·¯ºí ½Ã½º ½ÃÀå : Áö¿ª º¯µ¿ ºÐ¼®
  • ½ºÆ¼¾î·¯ºí ½Ã½º ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø¡¤µ¿Ç⠺м®, 2018-2030³â
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ½º¿þµ§
    • ³ë¸£¿þÀÌ
    • µ§¸¶Å©
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • È£ÁÖ
    • ű¹
    • Çѱ¹
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ¾Æ¸£ÇîÆ¼³ª
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • Äí¿þÀÌÆ®

Á¦8Àå °æÀï ±¸µµ

  • ÁÖ¿ä Á¦Á¶¾÷ü¿¡ ÀÇÇÑ ÃÖ±Ù µ¿Çâ°ú ¿µÇ⠺м®
  • ±â¾÷/°æÀï ºÐ·ù
  • º¥´õ ±¸µµ
KSA 24.05.20

Steerable Sheaths Market Growth And Trends

The global steerable sheaths market size is anticipated to reach USD 1,310 million by 2030 and is projected to grow at a CAGR of 7.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. The key factors contributing to market growth demands for minimally invasive procedures, the rising prevalence of cardiovascular & neurological diseases, technological advancements, and expanding applications in emerging fields.

The growing number of catheter ablation procedures is expected to positively impact on the market. As the number of ablation procedures rises, a direct increase in demand for steerable sheaths is observed, which are essential components for guiding catheters. Furthermore, steerable sheaths enhance maneuverability for navigating complex anatomies, provide greater flexibility for reaching targeted areas, improve compatibility, and enhance visualization capability through integrated imaging capabilities.

Technological advancements have supported new application development and aligned procedures with enhanced patency. Incorporating a steerable sheath with visualization technologies, such as an Electroanatomical Mapping (EAM) system, is expected to boost the market growth. According to an article published by the European Heart Rhythm Association in March 2023, using visualizable steerable sheaths for catheter ablation procedures reduced radiation exposure when compared to non-visualizable steerable sheaths.

Steerable Sheaths Market Report Highlights:

  • Based on the type, the single-use segment led the market with the largest revenue share of 95.6% in 2023. Growth of the segment can be attributed to the convenience & cost-effectiveness, material innovation, and higher focus on user-friendliness
  • Based on the application, the electrophysiology procedure segment led the market in 2023 with the largest revenue share of 38.8%. Growth of the segment can be attributed to the rising prevalence of arrhythmias, increasing adoption of catheter ablation, and advancements in steerable sheaths
  • Based on the end-use, the ambulatory surgical centers segment is anticipated to grow at the fastest CAGR over the forecast period. The segment growth can be attributed to the minimally invasive nature of the procedure with a shorter procedure time, higher cost-efficiency, reduced recovery time, and government bodies promoting steerable sheath-related procedures in an outpatient setting
  • North America dominated the market with the revenue share of 37.2% in 2023. The rising incidence of cardiovascular disease, advanced healthcare infrastructure, and the presence of key players. In addition, the increasing number of patients undergoing surgeries and the rising awareness about minimally invasive surgeries are expected to propel market growth in North America

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Application
    • 1.2.3. Portability
    • 1.2.4. End-use
    • 1.2.5. Regional scope
    • 1.2.6. Estimates and forecast timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity price analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type Segment
    • 2.2.2. Application Segment
    • 2.2.3. End-use Segment
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Global Steerable Sheaths Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Steerable Sheaths Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic Landscape

Chapter 4. Steerable Sheaths Market: Type Estimates & Trend Analysis

  • 4.1. Steerable Sheaths Market: Type Dashboard
  • 4.2. Steerable Sheaths Market: Type Movement Analysis
  • 4.3. Steerable Sheaths Market Size & Forecasts and Trend Analysis, 2018 to 2030
    • 4.3.1. Single-Use Steerable Sheath
      • 4.3.1.1. Market estimates and forecast, 2018 to 2030 (USD Million)
    • 4.3.2. Reprocessed Steerable Sheath
      • 4.3.2.1. Market estimates and forecast, 2018 to 2030 (USD Million)

Chapter 5. Steerable Sheaths Market: Application Estimates & Trend Analysis

  • 5.1. Steerable Sheaths Market: Application Dashboard
  • 5.2. Steerable Sheaths Market: Application Movement Analysis
  • 5.3. Steerable Sheaths Market Size & Forecasts and Trend Analysis, 2018 to 2030
    • 5.3.1. Electrophysiology (EP) Procedures
      • 5.3.1.1. Market estimates and forecast, 2018 to 2030 (USD Million)
    • 5.3.2. Interventional Cardiology Procedures
      • 5.3.2.1. Market estimates and forecast, 2018 to 2030 (USD Million)
    • 5.3.3. Peripheral Vascular Procedures
      • 5.3.3.1. Market estimates and forecast, 2018 to 2030 (USD Million)
    • 5.3.4. Other Procedures
      • 5.3.4.1. Market estimates and forecast, 2018 to 2030 (USD Million)

Chapter 6. Steerable Sheaths Market: End-use Estimates & Trend Analysis

  • 6.1. Steerable Sheaths Market: End-use Dashboard
  • 6.2. Steerable Sheaths Market: End-use Movement Analysis
  • 6.3. Steerable Sheaths Market Size & Forecasts and Trend Analysis, 2018 to 2030
    • 6.3.1. Hospitals & Clinics
      • 6.3.1.1. Market estimates and forecast, 2018 to 2030 (USD Million)
    • 6.3.2. Ambulatory Surgical Centers
      • 6.3.2.1. Market estimates and forecast, 2018 to 2030 (USD Million)

Chapter 7. Regional Estimates & Trend Analysis by Type, Application, & End-use

  • 7.1. Global Steerable Sheaths Market: Regional Dashboard
  • 7.2. Global Steerable Sheaths Market: Regional Movement Analysis
  • 7.3. Global Steerable Sheaths Market Size & Forecasts and Trend Analysis, by Type, Application, and End-use, 2018 to 2030
  • 7.4. North America
    • 7.4.1. U.S.
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.4.2. Canada
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. UK
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. UK market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.2. Germany
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Germany market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.3. France
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. France market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.4. Italy
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Italy market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.5. Spain
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. Spain market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.6. Sweden
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.7. Norway
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Regulatory framework/ reimbursement structure
      • 7.5.7.3. Competitive scenario
      • 7.5.7.4. Norway market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.8. Denmark
      • 7.5.8.1. Key country dynamics
      • 7.5.8.2. Regulatory framework/ reimbursement structure
      • 7.5.8.3. Competitive scenario
      • 7.5.8.4. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. China
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. China market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Japan market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.3. India
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework/ reimbursement structure
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. India market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.4. Australia
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework/ reimbursement structure
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Australia market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.5. Thailand
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework/ reimbursement structure
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework/ reimbursement structure
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Brazil
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.2. Mexico
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. Saudi Arabia
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework/ reimbursement structure
      • 7.8.1.3. Competitive scenario
      • 7.8.1.4. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework/ reimbursement structure
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.8.3. UAE
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Regulatory framework/ reimbursement structure
      • 7.8.3.3. Competitive scenario
      • 7.8.3.4. UAE market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.8.4. Kuwait
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Regulatory framework/ reimbursement structure
      • 7.8.4.3. Competitive scenario
      • 7.8.4.4. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Manufacturers
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2023
    • 8.3.4. Medtronic
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Application benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Boston Scientific Corporation
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Application benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Abbott
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Application benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Stryker
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Application benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Teleflex Incorporated
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Application benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Johnson & Johnson Services, Inc
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Application benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Baylis Medical Company, Inc
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Application benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Integer Holdings Corporation
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Application benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Merit Medical Systems
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Application benchmarking
      • 8.3.12.4. Strategic initiatives
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦